Rosetta Genomics Ltd (ROSG) Stock Price, Quote, News and Overview
NASDAQ:ROSG - Nasdaq -
ROSG Quote, Performance and Key Statistics
NASDAQ:ROSG (5/21/2018, 8:00:00 PM)
0.43
0 (0%)
The current stock price of ROSG is 0.43 null. In the past month the price increased by 22.86%. In the past year, price decreased by -78.06%.
About ROSG
Company Profile
Rosetta Genomics is a leader in the field of microRNA. The company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic and therapeutic tools, focusing primarily on cancer and various women's health indications.
Company Info
Rosetta Genomics Ltd
10 PLAUT STREET SCIENCE PARK
REHOVOT L3 76706
CEO: Kenneth A. Berlin
Phone: 972-73-222-0700
Rosetta Genomics Ltd / ROSG FAQ
What is the stock price of Rosetta Genomics Ltd today?
The current stock price of ROSG is 0.43 null.
What is the ticker symbol for Rosetta Genomics Ltd stock?
The exchange symbol of Rosetta Genomics Ltd is ROSG and it is listed on the Nasdaq exchange.
On which exchange is ROSG stock listed?
ROSG stock is listed on the Nasdaq exchange.
What is Rosetta Genomics Ltd worth?
Rosetta Genomics Ltd (ROSG) has a market capitalization of 2.55M null. This makes ROSG a Nano Cap stock.
What are the support and resistance levels for Rosetta Genomics Ltd (ROSG) stock?
Rosetta Genomics Ltd (ROSG) has a support level at 0.41 and a resistance level at 0.43. Check the full technical report for a detailed analysis of ROSG support and resistance levels.
Should I buy Rosetta Genomics Ltd (ROSG) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ROSG, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ROSG, evaluating the profitability, health, valuation and growth aspects
- Rosetta Genomics Ltd (ROSG) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Rosetta Genomics Ltd (ROSG) Sales and EPS estimates to see what analysts future expectations are.
- Rosetta Genomics Ltd (ROSG) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Rosetta Genomics Ltd (ROSG) Insider and Institutional Ownership to learn about the owners and their transactions.
- Rosetta Genomics Ltd (ROSG) Stock Chart to make your own analysis
- Rosetta Genomics Ltd (ROSG) Latest news and press-releases to stay up to date.
Does Rosetta Genomics Ltd (ROSG) stock pay dividends?
ROSG does not pay a dividend.
What is the Price/Earnings (PE) ratio of Rosetta Genomics Ltd (ROSG)?
Rosetta Genomics Ltd (ROSG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-9.31).
ROSG Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to ROSG. When comparing the yearly performance of all stocks, ROSG is a bad performer in the overall market: 85.1% of all stocks are doing better.
ROSG Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ROSG. ROSG may be in some trouble as it scores bad on both profitability and health.
ROSG Financial Highlights
Over the last trailing twelve months ROSG reported a non-GAAP Earnings per Share(EPS) of -9.31. The EPS increased by 32.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -190.2% | ||
| ROA | -229.85% | ||
| ROE | -1298.18% | ||
| Debt/Equity | 0 |